Antonio Tursi Selected Research

Antonio Tursi Research Topics

Disease

31	Diverticular Diseases 01/2020 - 01/2004
30	Diverticulitis 06/2022 - 01/2004
22	Ulcerative Colitis 02/2022 - 11/2004
19	Crohn Disease (Crohn's Disease) 02/2022 - 01/2003
14	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 05/2022 - 11/2011
9	Celiac Disease (Celiac Sprue) 08/2013 - 07/2002
7	Inflammation (Inflammations) 03/2021 - 01/2009
7	Infections 01/2020 - 07/2002
6	Colitis 10/2021 - 08/2005
6	Diverticulum 01/2021 - 09/2008
6	Abdominal Pain (Pain, Abdominal) 09/2018 - 03/2015
5	COVID-19 04/2022 - 01/2020
4	Necrosis 10/2020 - 12/2011
3	Pain (Aches) 03/2015 - 07/2013
2	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2021 - 01/2015
2	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 08/2012
2	Peptic Ulcer (Peptic Ulcers) 08/2011 - 12/2004
2	Gastritis 08/2011 - 12/2004
2	Chronic Hepatitis C 09/2007 - 04/2004
2	Lactose Intolerance (Intolerance, Lactose) 01/2006 - 04/2003
2	Diarrhea 05/2004 - 01/2003
1	Atrophic Gastritis 01/2022
1	Achlorhydria (Hypochlorhydria) 01/2022
1	Morbid Obesity 01/2021
1	Constipation 01/2021
1	Gastroesophageal Reflux (GERD) 01/2021
1	Dyspepsia (Indigestion) 01/2021
1	Venous Thromboembolism 07/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Colonic Polyps 01/2020
1	Carcinoma (Carcinomatosis) 12/2019
1	Gitelman Syndrome 01/2019
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 08/2018
1	Hidradenitis Suppurativa 12/2016
1	Obesity 01/2015
1	Type I Syndactyly 09/2014
1	Colonic Diverticulitis 08/2014
1	Fever (Fevers) 08/2014
1	Ulcer 07/2013

Drug/Important Bio-Agent (IBA)

23	Mesalamine (Mesalazine)FDA LinkGeneric 01/2020 - 01/2004
14	Adalimumab (Humira)FDA Link 05/2022 - 09/2008
14	Infliximab (Remicade)FDA Link 02/2022 - 02/2011
11	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 01/2004
10	Leukocyte L1 Antigen Complex (Calgranulin)IBA 06/2022 - 01/2009
10	Rifaximin (L 105)FDA Link 01/2020 - 04/2003
7	AntibodiesIBA 12/2021 - 03/2003
5	golimumab FDA Link 12/2021 - 11/2016
5	C-Reactive ProteinIBA 01/2021 - 08/2014
5	Proton Pump InhibitorsIBA 01/2021 - 08/2011
5	Pharmaceutical PreparationsIBA 10/2016 - 04/2003
4	Biosimilar PharmaceuticalsIBA 05/2022 - 12/2017
4	SteroidsIBA 01/2021 - 06/2006
4	Budesonide (Pulmicort)FDA LinkGeneric 12/2019 - 06/2006
4	balsalazide (Colazal)FDA LinkGeneric 12/2009 - 11/2004
3	CT-P13IBA 02/2022 - 12/2017
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2012
3	Clarithromycin (Biaxin)FDA LinkGeneric 06/2012 - 07/2002
3	Amoxicillin (Wymox)FDA LinkGeneric 08/2011 - 07/2002
3	Lactose FDA LinkGeneric 03/2006 - 04/2003
2	Ustekinumab (CNTO 1275)FDA Link 08/2021 - 01/2021
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 09/2008
2	Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric 01/2020 - 09/2008
2	Syndecan-1 (Syndecan 1)IBA 09/2014 - 09/2014
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2014 - 09/2014
2	Tinidazole FDA Link 08/2011 - 12/2004
2	ProdrugsIBA 12/2009 - 09/2008
2	Beclomethasone (Beclometasone)FDA Link 06/2006 - 08/2005
2	Lactulose (Duphalac)FDA LinkGeneric 03/2006 - 04/2003
2	ranitidine bismuth citrate (Tritec)FDA Link 12/2004 - 07/2002
2	RNA (Ribonucleic Acid)IBA 04/2004 - 07/2002
2	TransglutaminasesIBA 11/2003 - 03/2003
2	Glutens (Glutelin)IBA 01/2003 - 07/2002
1	GP2017IBA 05/2022
1	Biological ProductsIBA 04/2022
1	antineoplaston A10 (A 10)IBA 01/2022
1	CarcinogensIBA 01/2022
1	AcetaldehydeIBA 01/2022
1	Cysteine (L-Cysteine)FDA Link 01/2022
1	risankizumabIBA 11/2021
1	Omalizumab (Xolair)FDA Link 10/2021
1	pembrolizumabIBA 05/2021
1	Hemoglobins (Hemoglobin)IBA 01/2021
1	gingerolIBA 01/2021
1	Angiotensin Receptor AntagonistsIBA 01/2020
1	SmokeIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Monoclonal AntibodiesIBA 01/2020
1	vedolizumabIBA 08/2019
1	Interleukin-10 (Interleukin 10)IBA 12/2018
1	Vitamin D FDA LinkGeneric 12/2016
1	prucaloprideIBA 04/2016
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2015
1	AcidsIBA 05/2014
1	Capsules (Microcapsules)IBA 08/2013
1	Bevacizumab (Avastin)FDA Link 08/2012

Therapy/Procedure

24	Therapeutics 12/2021 - 07/2002
7	Gluten-Free Diet 01/2015 - 04/2003
4	Aftercare (After-Treatment) 08/2012 - 09/2007
1	Appendectomy 01/2020
1	Conservative Treatment 11/2013